Financial results that surpass expectations typically lead to a positive reaction in the stock market as it indicates the company is performing better than what analysts and investors anticipated. For Sarepta Therapeutics, the better-than-expected Q4 results suggest strong operational performance and financial health, which naturally boosts investor confidence and can lead to an increase in stock price.